1 false false false false false false false false false false true false false false false false false No description of principal activity 2025-04-01 Sage Accounts Production Advanced 2025 - FRS102_2025 xbrli:pure xbrli:shares iso4217:GBP 15696991 2025-04-01 2026-03-31 15696991 2026-03-31 15696991 2025-03-31 15696991 2024-04-30 2025-03-31 15696991 2025-03-31 15696991 2024-04-29 15696991 core:MotorVehicles 2025-04-01 2026-03-31 15696991 bus:Director1 2025-04-01 2026-03-31 15696991 core:WithinOneYear 2026-03-31 15696991 core:WithinOneYear 2025-03-31 15696991 core:MotorVehicles 2025-03-31 15696991 core:MotorVehicles 2026-03-31 15696991 core:ShareCapital 2026-03-31 15696991 core:ShareCapital 2025-03-31 15696991 core:RetainedEarningsAccumulatedLosses 2026-03-31 15696991 core:RetainedEarningsAccumulatedLosses 2025-03-31 15696991 core:MotorVehicles 2025-03-31 15696991 bus:SmallEntities 2025-04-01 2026-03-31 15696991 bus:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 15696991 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 15696991 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 15696991 bus:FullAccounts 2025-04-01 2026-03-31 15696991 core:ComputerEquipment 2025-04-01 2026-03-31 15696991 core:ComputerEquipment 2025-03-31 15696991 core:ComputerEquipment 2026-03-31
COMPANY REGISTRATION NUMBER: 15696991
LANCASHIRE MSK & SPINE SOLUTIONS LIMITED
FILLETED UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 March 2026
LANCASHIRE MSK & SPINE SOLUTIONS LIMITED
STATEMENT OF FINANCIAL POSITION
31 March 2026
2026
2025
Note
£
£
FIXED ASSETS
Tangible assets
5
22,950
29,297
CURRENT ASSETS
Debtors
6
59
39
Cash at bank and in hand
19,764
15,748
---------
---------
19,823
15,787
CREDITORS: amounts falling due within one year
7
37,128
40,129
---------
---------
NET CURRENT LIABILITIES
17,305
24,342
---------
---------
TOTAL ASSETS LESS CURRENT LIABILITIES
5,645
4,955
--------
--------
NET ASSETS
5,645
4,955
--------
--------
CAPITAL AND RESERVES
Called up share capital
100
100
Profit and loss account
5,545
4,855
--------
--------
SHAREHOLDERS FUNDS
5,645
4,955
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 31st March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
LANCASHIRE MSK & SPINE SOLUTIONS LIMITED
STATEMENT OF FINANCIAL POSITION (continued)
31 March 2026
These financial statements were approved by the board of directors and authorised for issue on 25 June 2026 , and are signed on behalf of the board by:
Mr P P Veerappa
Director
Company registration number: 15696991
LANCASHIRE MSK & SPINE SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
YEAR ENDED 31st MARCH 2026
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 20 Mannin Way, Lancaster Business Park, Caton Road, Lancaster, LA1 3SW.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Motor vehicles
-
25% reducing balance
Equipment
-
20% reducing balance
4. EMPLOYEE NUMBERS
The average number of persons employed by the company during the year amounted to 1 (2025: 1 ).
5. TANGIBLE ASSETS
Motor vehicles
Equipment
Total
£
£
£
Cost
At 1st April 2025
37,000
1,934
38,934
Additions
1,125
1,125
---------
--------
---------
At 31st March 2026
37,000
3,059
40,059
---------
--------
---------
Depreciation
At 1st April 2025
9,250
387
9,637
Charge for the year
6,938
534
7,472
---------
--------
---------
At 31st March 2026
16,188
921
17,109
---------
--------
---------
Carrying amount
At 31st March 2026
20,812
2,138
22,950
---------
--------
---------
At 31st March 2025
27,750
1,547
29,297
---------
--------
---------
6. DEBTORS
2026
2025
£
£
Prepayments and accrued income
59
39
-----
-----
7. CREDITORS: amounts falling due within one year
2026
2025
£
£
Accruals and deferred income
1,260
851
Corporation tax
2,693
3,890
Social security and other taxes
72
115
Director loan accounts
33,103
35,273
---------
---------
37,128
40,129
---------
---------
8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES
The director has a loan accounts with the company which remained in credit throughout the year. At the year end the balance was £33,103 (2025 - £35,273) which is included in creditors.